Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 3/20 | 0.68 |
| ▸ | ENPP2 | Q13822 | 6/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | PLG | P00747 | 1/20 | 0.43 |
| ▸ | F12 | P00748 | 1/20 | 0.43 |
| ▸ | F11 | P03951 | 1/20 | 0.43 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL971732 | 0.88 | MGLL (0.73) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL5439666 | 0.86 | MGLL (0.70) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL30990837 | 0.86 | MGLL (0.55) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL28377496 | 0.86 | MGLL (0.55) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL30038945 | 0.86 | MGLL (0.55) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL1093668 | 0.86 | MGLL (0.55) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL29610130 | 0.85 | MGLL (0.58) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL622947 | 0.85 | MGLL (0.58) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL31512204 | 0.83 | MGLL (0.56) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL14738438 | 0.83 | MGLL (0.56) | MGLLENPP2CA4CA6CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1903020-B1 | BIPHENYL DERIVATIVES, ORGANIC ELECTROLUMINESCENT MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO (JP) | 2014-03-19 | — | — | EP | disclosed |
| US-7560604-B2 | Biphenyl derivative, material for organic electroluminescence device, and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2009-07-14 | — | — | US | disclosed |
| EP-1903020-A1 | BIPHENYL DERIVATIVES, ORGANIC ELECTROLUMINESCENT MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-03-26 | — | — | EP | disclosed |
| US-20070013296-A1 | Biphenyl derivative, material for organic electroluminescence device, and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070013296-A1 | Biphenyl derivative, material for organic electroluminescence device, and organic electroluminescence device using the same | EED, BMI1, EBPL | MGLL 245/4885ENPP2 3255/4885CA4 4093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.